Related Experiment Video
Updated: Feb 5, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Bacteriophage-resistant industrial fermentation strains: from the cradle to CRISPR/Cas9
1Cognogen Biotechnology Consulting, 7636 Andora Drive, Sarasota, FL, 34238, USA. rbaltz923@gmail.com.
Abstract:
Bacteriophage contamination and cell lysis have been recurring issues with some actinomycetes used in the pharmaceutical fermentation industry since the commercialization of streptomycin in the 1940s. In the early years, spontaneous phage-resistant mutants or lysogens were isolated to address the problem. In some cases, multiple phages were isolated from different contaminated fermentors, so strains resistant to multiple phages were isolated to stabilize the fermentation processes. With the advent of recombinant DNA technology, the early scaleup of the Escherichia coli fermentation process for the production of human insulin A and B chains encountered contamination with multiple coliphages. A genetic engineering solution was to clone and express a potent restriction/modification system in the production strains. Very recently, an E. coli fermentation of 1,3-propanediol was contaminated by a coliphage related to T1. CRISPR/Cas9 technology was applied to block future contamination by targeting seven different phage genes for double-strand cleavage. These approaches employing spontaneous mutation, genetic engineering, and synthetic biology can be applied to many current and future microorganisms used in the biotechnology industry.
Insights
Bacteriophage contamination is a persistent problem in industrial fermentation. Solutions range from isolating resistant strains to using advanced CRISPR–Cas9 gene editing for robust microbial production.
Area of Science:
- Microbiology
- Biotechnology
- Industrial Fermentation
Background:
- Bacteriophage contamination and cell lysis have plagued actinomycete fermentations since the 1940s, impacting pharmaceutical production.
- Contamination issues have also affected Escherichia coli fermentations, including those for human insulin and 1,3-propanediol production.
Purpose of the Study:
- To review historical and modern strategies for mitigating bacteriophage contamination in industrial fermentation processes.
- To highlight the evolution of solutions from spontaneous mutation to advanced genetic engineering and synthetic biology.
Main Methods:
- Isolation of spontaneous phage-resistant mutants and lysogens.
- Application of recombinant DNA technology to introduce restriction/modification systems.
- Utilizing CRISPR–Cas9 technology to target and cleave specific phage genes.
Main Results:
- Historically, resistant strains and genetic engineering have stabilized fermentation processes.
- CRISPR–Cas9 effectively blocked coliphage contamination by targeting multiple phage genes.
- These diverse methods offer broad applicability to various industrial microorganisms.
Conclusions:
- Bacteriophage contamination remains a significant challenge in industrial biotechnology.
- A spectrum of techniques, from classical to synthetic biology, can effectively manage phage contamination.
- These strategies are crucial for ensuring stable and efficient microbial fermentation for diverse biotechnological applications.
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Fermentation
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
CRISPR/Cas9 Genome Editing
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages

